CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services


This is an archived document. The links are no longer being updated.

TB Notes 1, 2002

New CDC Publications

Besser RE, Pakiz B, Schulte JM, Alvarado S, Zell ER, Kenyon TA, Onorato IM. Risk factors for positive Mantoux tuberculin skin tests in children in San Diego, California: evidence for boosting and possible foodborne transmission. Pediatrics 2001; 108(2): 305-310.

Bock NN, Sales RM, Rogers T, DeVoe B. A spoonful of sugar... : improving adherence to tuberculosis treatment using financial incentives. Int J Tuberc Lung Dis 2001; 5(1): 96-98.

Conover C, Ridzon R, Valway S, et al. Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis 2001;5(1):59-64.

Dale JW, Brittain D, Cataldi AA, Cousins D, Crawford JT, et al. Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int J Tuberc Lung Dis 2001;5(3):216-219.

Fitzpatrick LK, Hardacker JA, Heirendt W, Agerton T, Streicher A, Melnyk H, Ridzon R, Valway S, Onorato I. A preventable outbreak of tuberculosis investigated through an intricate social network. Clin Infect Dis 2001;33:1801-1806.

Johnson J, Okwera A, Hom DL, Mayanja H, Kityo CM, Nsubuga P, Nakibali JG, Loughlin AM, Yun H, Mugyenyi PN, Vernon A, Mugerwa RD, Ellner JJ, Whalen CC. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS 2001;15:2137-2147.

Lounis N, Bentoucha A, Truffot-Pernot C, Ji B, O'Brien RJ, Vernon A, Roscigno G, Grosset J. Effectiveness of once-weekly rifapentine- and moxifloxacin-containing regimens against Mycobacterium tuberculosis in mice. Antimicrob Agent Chemother 2001;45:3482-3486.

Murthy KJR, Frieden TR, Yazdani A, Hreshikesh P. Public-private partnership in tuberculosis control: experience in Hyderabad, India. Int J Tuberc Lung Dis 2001;5(4):354-359.

O'Brien R (responsible author). Global Alliance for TB Drug Development. Scientific blueprint for TB drug development. Tuberculosis 2001;81(Suppl 1):1-52.

Range N, Ipuge YA, O'Brien RJ, et al. Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998. Int J Tuberc Lung Dis 2001; 5(5): 405-412.

Sackoff JE, Torian LV, Frieden TR. TB prevention in HIV clinics in New York City. Int J Tuberc Lung Dis 2001;5(2):123-128.

Saiman L, San Gabriel P, Schulte JM, Vargas MP, Kenyon T, Onorato IM. Risk factors for latent tuberculosis infection among children in New York City. Pediatrics 2001;107(5):999-1003.

Schulte JM, Valway SE, McCray E, Onorato IM. Tuberculosis cases reported among migrant farm workers in the United States, 1993-97. Journal of Health Care for the Poor and Underserved 2001;12(3):311-322.

Small PM and Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001;345(3):189-200.

Tanzania Tuberculin Survey Collaboration. Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983-1998. Int J Tuberc Lung Dis 2001;5(2):103-112.

Taylor Z, O'Brien RJ. TB elimination: are we willing to pay the price? (editorial). Am J Respir Crit Care Med 2001;163:1-2.

Tuberculosis Research Centre, Chetput, Chennai, India. Trends in the prevalence and incidence of tuberculosis in South India. Int J Tuberc Lung Dis 2001;5(2):142-157.

Villarino EM and Clairy M. Tuberculosis due to environment, biology, or both? Chest 2001;120(5):11435-1437. Editorial.


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333